Notice 21 Aug 2025 compliance, business regulation, pharmaceuticals, dea, controlled substances, drug enforcement

💊DEA Notice on Continuus Pharmaceuticals' Bulk Manufacturing Application

Continuus Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 20 Aug 2025 compliance, healthcare, dea, florida, drug enforcement, medical regulations

🚫DEA Revokes Registration for Physician Following License Suspension

The Drug Enforcement Administration has issued an Order to Show Cause for the revocation of Kenneth Pherson, D.O.'s registration, citing the suspension of his state medical license in Florida. This decision emphasizes the necessity for practitioners to maintain state authority to prescribe controlled substances, as federal compliance hinges on state licensure. The document details the procedural actions taken by the DEA and the implications of default by the registrant.

Learn More
Rule 15 Aug 2025 compliance, administrative practice and procedure, reporting and recordkeeping requirements, drug regulation, dea, controlled substances, drug traffic control, public safety, synthetic opioids

⚖️DEA Temporarily Schedules New Synthetic Opioids - Compliance Needed

The Drug Enforcement Administration issues this temporary order to schedule two benzimidazole-opioids in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to avoid imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.

Learn More
Notice 11 Aug 2025 iowa, controlled substances, regulatory compliance, dea, pharmaceuticals, drug manufacturing

💊Cambrex Charles City Seeks Registration for Controlled Substance Manufacturing

Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 11 Aug 2025 business compliance, controlled substances, healthcare, drug enforcement, clinical trials, dea, benuvia operations

💊Benuvia Operations LLC Applies for Controlled Substances Import Registration

Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 11 Aug 2025 business regulation, controlled substances, pharmaceuticals, compliance, drug enforcement, dea

💊DEA Notice

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 11 Aug 2025 controlled substances, drug importation, pharmaceuticals, compliance, regulation, dea

💊DEA Notice

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 11 Aug 2025 controlled substances, drug importation, pharmaceuticals, compliance, dea

💊DEA Notice on Experic LLC's Importer Application for Controlled Substances

Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 8 Aug 2025 compliance, controlled substances, business regulation, drug enforcement, dea, manufacturing

💊Chemtos LLC's Application for Bulk Manufacturing of Controlled Substances

Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Jul 2025 compliance, healthcare, dea, florida, drug enforcement, medical regulation

🚫DEA Revokes Registration of Dr. Taha Dias for Prescription Violations

The Drug Enforcement Administration issued a decision to revoke the DEA Certificate of Registration for Dr. Taha Dias, citing repeated violations of federal and Florida state law related to the improper issuance of prescriptions for controlled substances without legitimate medical purpose, jeopardizing public safety and regulatory compliance.

Learn More